Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria
- PMID: 22110737
- PMCID: PMC3218025
- DOI: 10.1371/journal.pone.0027714
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria
Abstract
The host immune response contributes to the onset and progression of severe malaria syndromes, such as cerebral malaria. Adjunctive immunomodulatory strategies for severe malaria may improve clinical outcome beyond that achievable with artemisinin-based therapy alone. Here, we report that prophylaxis with inhaled nitric oxide significantly reduced systemic inflammation (lower TNF, IFNγ and MCP-1 in peripheral blood) and endothelial activation (decreased sICAM-1 and vWF, and increased angiopoeitin-1 levels in peripheral blood) in an experimental cerebral malaria model. Mice that received inhaled nitric oxide starting prior to infection had reduced parasitized erythrocyte accumulation in the brain, decreased brain expression of ICAM-1, and preserved vascular integrity compared to control mice.Inhaled nitric oxide administered in combination with artesunate, starting as late as 5.5 days post-infection, improved survival over treatment with artesunate alone (70% survival in the artesunate only vs. 100% survival in the artesunate plus iNO group, p = 0.03). These data support the clinical investigation of inhaled nitric oxide as a novel adjunctive therapy in patients with severe malaria.
Conflict of interest statement
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3218025/bin/pone.0027714.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3218025/bin/pone.0027714.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3218025/bin/pone.0027714.g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3218025/bin/pone.0027714.g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3218025/bin/pone.0027714.g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3218025/bin/pone.0027714.g006.gif)
Similar articles
-
Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.Int Immunopharmacol. 2017 Jul;48:219-230. doi: 10.1016/j.intimp.2017.05.008. Epub 2017 May 19. Int Immunopharmacol. 2017. PMID: 28531845
-
Inhaled nitric oxide and cerebral malaria: basis of a strategy for buying time for pharmacotherapy.Pediatr Infect Dis J. 2012 Dec;31(12):e250-4. doi: 10.1097/INF.0b013e318266c113. Pediatr Infect Dis J. 2012. PMID: 22760538 Review.
-
Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.J Neuroinflammation. 2011 Jun 7;8:66. doi: 10.1186/1742-2094-8-66. J Neuroinflammation. 2011. PMID: 21649904 Free PMC article.
-
S1P is associated with protection in human and experimental cerebral malaria.Mol Med. 2011;17(7-8):717-25. doi: 10.2119/molmed.2010.00214. Epub 2011 May 5. Mol Med. 2011. PMID: 21556483 Free PMC article.
-
Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics.Curr Opin Hematol. 2011 May;18(3):177-85. doi: 10.1097/MOH.0b013e328345a4cf. Curr Opin Hematol. 2011. PMID: 21423010 Review.
Cited by
-
Pathogenetic mechanisms and treatment targets in cerebral malaria.Nat Rev Neurol. 2023 Nov;19(11):688-709. doi: 10.1038/s41582-023-00881-4. Epub 2023 Oct 19. Nat Rev Neurol. 2023. PMID: 37857843 Review.
-
Cerebrospinal fluid biomarkers provide evidence for kidney-brain axis involvement in cerebral malaria pathogenesis.Front Hum Neurosci. 2023 May 2;17:1177242. doi: 10.3389/fnhum.2023.1177242. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37200952 Free PMC article.
-
Potential Benefits of Lycopene Consumption: Rationale for Using It as an Adjuvant Treatment for Malaria Patients and in Several Diseases.Nutrients. 2022 Dec 14;14(24):5303. doi: 10.3390/nu14245303. Nutrients. 2022. PMID: 36558462 Free PMC article. Review.
-
Nitric oxide in parasitic infections: a friend or foe?J Parasit Dis. 2022 Dec;46(4):1147-1163. doi: 10.1007/s12639-022-01518-x. Epub 2022 Jul 18. J Parasit Dis. 2022. PMID: 36457767 Free PMC article. Review.
-
The association between acute fatty liver disease and nitric oxide during malaria in pregnancy.Malar J. 2021 Dec 14;20(1):462. doi: 10.1186/s12936-021-03999-2. Malar J. 2021. PMID: 34906158 Free PMC article.
References
-
- Dondorp A, Nosten F, Stepniewska K, Day N White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366:717–725. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous